Biomedical research tools from the seabed

Current Opinion in Drug Discovery and Development

Volumn 10, Issue 2, 2007, Pages 145-152

  Folmer, Florence ^a   Houssen, Wael E ^a   Scott, Roderick H ^b   Jaspars, Marcel ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Biomedical research tool; Cone shell toxin; Conotoxin; Intracellular signaling; Ion channel; Marine natural product; Membrane processes

Indexed keywords

AETX K; AM 336; AMPHILECTENE DERIVATIVE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; BOLINAQUINONE; CALCIUM CHANNEL; CEPHALOSTATIN 1; CGX 1160; CONANTOKIN G; CONOTOXIN; CURACIN A; CYCLOAMPHILECTENE DERIVATIVE; CYCLOPRODIGIOSIN; EPITAONDIOL; LATRUNCULIN A; LO 959; OMEGA CONOTOXIN MVIIA; PACIFENOL; PROSTAGLANDIN SYNTHASE INHIBITOR; PSAMMAPLIN A; PYRIDINIUM DERIVATIVE; SESQUITERPENE; SMENOSPONGIDINE; SMENOSPONGINE; SMENOSPONGORINE; STYPOTRIOL TRIACETATE; TRIGONELLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARIOLIN B;

B CELL LYMPHOMA; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CHRONIC PAIN; LEUKEMIA CELL; MARINE ENVIRONMENT; MEDICAL RESEARCH; NERVE ENDING; NEUROPROTECTION; NONHUMAN; REVIEW; SNAIL; STROKE;

ANIMALS; BIOMEDICAL RESEARCH; CELL MEMBRANE; HUMANS; ION CHANNELS; MARINE BIOLOGY; PEPTIDES;

EID: 33947326627     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR: Marine natural products. Nat Prod Rep (2006) 23(1):26-78.
2. Battershill C, Long P, Jaspars M: Marine biodiscovery: New drugs from the ocean depths. Biologist (2005) 52(2):107-114. An excellent general introduction to the field of marine natural products and their applications as well as major issues facing the field of marine biodiscovery.
3. Butler MS: Natural products to drugs: Natural product derived compounds in clinical trials. (2005) Nat Prod Rep 22(2):162-195.
4. Newman DJ, Cragg GM: Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod (2004) 67(8):1216-1238. A review which details the status of small-molecule therapeutics of marine origin in clinical and preclinical trials.
5. Visegrady B, Lorinczy D, Hild G, Somogyi B, Nyitrai M: A simple model for the cooperative stabilisation of actin filaments by phalloidin and jasplakinolide. FEBS Lett (2005) 579(1):6-10. An outstanding example of the use of a sponge natural product to investigate fundamental processes within the cell.
6. Terlau H, Olivera BM: Conus venoms: A rich source of novel ion channel-targeted peptides. (2004) Physiol Rev 84(1):41-68.
7. Chudakov DM, Lukyanov S, Lukyanov KA: Fluorescent proteins as a toolkit for in vivo imaging. Trends Biotechnol (2005) 23(12):605-613.
8. Turk T, Sepčić K, Mancini I, Guella G: 3-Alkylpyridinium and 3-alkylpyridine compounds from marine sponges, their synthesis, biological activities and potential use. In: Studies in Natural Product Chemistry (Bioactive Natural Products) (2007): in press.
9. McClelland D, Evans RM, Abidin I, Sharma S, Choudhry FZ, Jaspars M, Sepcic K, Scott RH: Irreversible and reversible pore formation by polymeric alkylpyridinium salts (poly-APS) from the sponge Reniera sarai. Br J Pharmacol (2003) 139(8):1399-1408.
10. Tucker SJ, McClelland D, Jaspars M, Sepcic K, MacEwan DJ, Scott RH: The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells. Biochim Biophys Acta Biomembr (2003) 1614(2):171-181. The application of transient membrane pores to deliver cDNA into cells. This is the first example of the use of pores to deliver genetic material.
11. McLaggan D, Adjimatera N, Sepçiç K, Jaspars M, MacEwan DJ, Blagbrough IS, Scott RH: Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: Distinct tools for intracellular delivery of cDNA and siRNA. BMC Biotechnol (2006) 6:6.
12. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature (2002) 415(6870):389-395.
13. Mancini I, Sicurelli A, Guella G, Turk T, Maček P, Sepčić K: Synthesis and bioactivity of linear oligomers related to polymeric alkylpyridinium metabolites from the Mediterranean sponge Reniera sarai. Org Biomol Chem (2004) 2(9):1368-1375.
14. Kaiser A, Billot X, Gateau-Olesker A, Marazano C, Das BC: Selective entry to the dimeric or oligomeric pyridinium sponge macrocycles via aminopentadienal derivatives. Possible biogenetic relevance with manzamine alkaloids. J Am Chem Soc (1998) 120(32):8026-8034.
15. Koss D, Hindley K, David K, Mancini I, Guella G, Sepčić K, Turk T, Rebolj K, Riedel G, Platt B, Scott R: A comparative study of the actions of alkylpyridinium salts from a marine sponge and related synthetic compounds in rat cultured hippocampal neurones. BMC Pharmacology (2007) 7:1
16. Llewellyn L: Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat Prod Rep (2006) 23(2):200-222. A review on saxitoxin and its analogs and their many biological activities, as viewed from an ecological context. Their interaction with known and proposed receptors is discussed.
17. LePage KT, Goeger D, Yokokawa F, Asano T, Shioiri T, Gerwick WH, Murray TF: The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol Lett (2005) 158(2):133-139.
18. Ständker L, Béress L, Garateix A, Christ T, Ravens U, Salceda E, Soto E, John H, Forssmann W-G, Aneiros A: A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon (2006) 48(2):211-220.
19. Wang CZ, Chi CW: Conus peptides - a rich pharmaceutical treasure. Acta Biochim Biophys Sin (Shanghai) (2004) 36(11):713-723.
20. Loughnan M, Nicke A, Jones A, Schroeder CI, Nevin ST, Adams DJ, Alewood PF, Lewis RJ: Identification of a novel class of nicotinic receptor antagonists - dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from Conus vexillum. J Biol Chem (2006) 281(34):24745-24755.
21. Rauck R, Wallace M, Leong M, MineHart M, Webster L, Charapata S, Abraham J, Buffington D, Ellis D, Kartzinel R: A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage (2006) 31(5):393-406. The results of the clinical trial of ziconotide that resulted in its approval for the treatment of chronic pain. This treatment is the first of its kind to be approved from a marine origin. Current investigations into conotoxins will undoubtedly lead to treatments for other types of pain.
22. Stix G: A toxin against pain. Sci Am (2005) 292(4):70-75.
23. Livett BG, Sandall DW, Keays D, Down J, Gayler KR, Satkunanathan N, Khalil Z: Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon (2006) 48(7):810- 829. A review that discusses the current treatments derived from conotoxins which are in, or nearing, clinical evaluation.
24. Sabareesh V, Gowd KH, Ramasamy P, Sudarslal S, Krishnan KS, Sikdar SK, Balaram P: Characterization of contryphans from Conus loroisii and Conus amadis that target calcium channels. Peptides (2006) 27(11):2647-2654.
25. Hasegawa Y, Honma T, Nagai H, Ishida M, Nagashima Y, Shiomi K: Isolation and cDNA cloning of a potassium channel peptide toxin from the sea anemone Anemonia erythraea. Toxicon (2006) 48(5):536-542.
26. + outward current (IK1) to the alkaloids lepadiformines A, B, and C. J Nat Prod (2006) 69(4):558-562.
27. Birinyi-Strachan LC, Gunning SJ, Lewis RJ, Nicholson GM: Block of voltage-gated potassium channels by Pacific ciguatoxin-1 contributes to increased neuronal excitability in rat sensory neurons. Toxicol Appl Pharmacol (2005) 204(2):175-186.
28. Houssen WE, Jaspars M, Wease KN, Scott RH: Acute actions of marine toxin latrunculin A on the electrophysiological properties of cultured dorsal root ganglion neurones. Comp Biochem Physiol C Toxicol Pharmacol (2006) 142(1-2):19-29.
29. Lange K, Gartzke J: F-actin-based Ca signalling - a critical comparison with the current concept of Ca signaling. J Cell Physiol (2006) 209(2):270-287.
30. Temraz TA, Houssen WE, Jaspars M, Woolley DR, Wease KN, Davies SN, Scott RH: A pyridinium derivative from Red Sea soft corals inhibited voltage-activated potassium conductances and increased excitability of rat cultured sensory neurones. BMC Pharmacol (2006) 6:10.
31. Terracciano S, Aquino M, Rodriquez M, Monti MC, Casapullo A, Riccio R, Gomez-Paloma L: Chemistry and biology of anti-inflammatory marine natural products: Molecules interfering with cyclooxygenase, NF-κB and other unidentified targets. Curr Med Chem (2006) 13(16):1947-1969.
32. Rovirosa J, Sepulveda M, Quezada E, San-martin A: Isoepitaondiol, a diterpenoid of Stypopodium flabelliforme and the insecticidal activity of stypotriol, epitaondiol and derivatives. Phytochemistry (1992) 31(8):2679-2681.
33. Rovirosa J, Astudillo L, Sanchez I, Palacios Y, Sanmartin A: Antimicrobial activity of halogenated sesquiterpenes of Laurencia claviformis from Easter Island. Bol Soc Chil Quim (1989) 34:147-152.
34. 2 inactivation by bolinaquinone. Chembiochem (2006) 7(6):971-980. Fundamental insight into the mechanism of action of phospholipase A2.
35. Catassi A, Cesario A, Arzani D, Menichini P, Alama A, Bruzzo C, Imperatori A, Rotolo N, Granone P, Russo P: Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells. Cell Mol Life Sci (2006) 63(19-20):2377-2386.
36. Lopez-Anton N, Rudy A, Barth N, Schmitz LM, Pettit GR, Schulze-Osthoff K, Dirsch VM, Vollmar AM: The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway. J Biol Chem (2006) 281(44):33078-33086. Insight into the mode of action of the extraordinarily toxic marine metabolite cephalostatin 1 (see also reference [37•].
37. Muller IM, Dirsch VM, Rudy A, Lopez-Anton N, Pettit GR, Vollmar AM: Cephalostatin 1 inactivates Bcl-2 by hyperphosphorylation independent of M-phase arrest and DNA damage. Mol Pharmacol (2005) 67(5):1684-1689. Further insight into the mode of action of the extraordinarily toxic marine metabolite cephalostatin 1 (see also reference [36•].
38. Mora FD, Jones DK, Desai PV, Patny A, Avery MA, Feller DR, Smillie T, Zhou YD, Nagle DG: Bioassay for the identification of natural product-based activators of peroxisome proliferator-activated receptor-? (PPAR?): The marine sponge metabolite psammaplin A activates PPAR? and induces apoptosis in human breast tumor cells. J Nat Prod (2006) 69(4):547-552.
39. Simone M, Erba E, Damia G, Vikhanskaya F, Di Francesco AM, Riccardi R, Bailly C, Cuevas C, Fernandez Sousa-Faro JM, D'Incalci M: Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity. Eur J Cancer (2005) 41(15):2366- 2377.
40. Aoki S, Kong D, Matsui K, Rachmat R, Kobayashi M: Sesquiterpene aminoquinones, from a marine sponge, induce erythroid differentiation in human chronic myelogenous leukemia, K562 cells. Chem Pharm Bull (2004) 52(8):935-937.
41. Aoki S, Kong D, Suna H, Sowa Y, Sakai T, Setiawan A, Kobayashi M: Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner. Biochem Biophys Res Commun (2006) 342(1):101-106.
42. Gul W, Hammond NL, Yousaf M, Bowling JJ, Schinazi RF, Wirtz SS, de Castro Andrews G, Cuevas C, Hamann MT: Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity. Bioorg Med Chem (2006) 14(24):8495-8505.
43. Allingham JS, Klenchin VA, Rayment I: Actin-targeting natural products: Structures, properties, and mechanisms of action. Cell Mol Life Sci (2006) 63(18):2119-2134.
44. Petchprayoon C, Stuwanborirux K, Tanaka JI, Yan Y, Sakata T, Marriott G: Fluorescent kabiramides: New probes to quantify actin in vitro and in vivo. Bioconjug Chem (2005) 16(6):1382- 1389. The synthesis and use of a number of fluorescent probes based around kabiramide C. These will be extremely valuable in the analysis of actin content in vitro and in vivo.
45. Haddock SH, Dunn CW, Pugh PR, Schnitzler CE: Bioluminescent and red-fluorescent lures in a deep-sea siphonophore. Science (2005) 309(5732):263.
46. Rees JF, de Wergifosse B, Noiset O, Dubuisson M, Janssens B, Thompson EM: The origins of marine bioluminescence: Turning oxygen defence mechanisms into deep-sea communication tools. J Exp Biol 1998, 201(Pt 8):1211-1221.
47. Sasaki K, Watanabe MF, Suda Y, Ishizuka A, Noparatnarapom N: Applications of photosynthetic bacteria for medical fields. J Biosci Bioeng (2005) 100(5):481-488.
48. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K: Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun (2005) 332(2):392-397.
49. ASSOCIATES OF CAPE COD INC (Wainwright NR, Novitsky TJ): Endotoxin binding and neutralizing protein and uses thereof. US-06384200 (2002).